Hairpin-like SiRNA-Based Spherical Nucleic Acids

Overview

Journal J Am Chem Soc

Publisher American Chemical Society

Specialty Chemistry

Date 2022 Feb 10

PMID 35143189

Authors

Matthew K Vasher

Gokay Yamankurt

Chad A Mirkin

Affiliations

Soon will be listed here.

Abstract

The therapeutic use of small interfering RNAs (siRNAs) as gene regulation agents has been limited by their poor stability and delivery. Although arranging siRNAs into a spherical nucleic acid (SNA) architecture to form siRNA-SNAs increases their stability and uptake, prototypical siRNA-SNAs consist of a hybridized architecture that causes guide strand dissociation from passenger strands, which limits the delivery of active siRNA duplexes. In this study, a new SNA design that directly attaches both siRNA strands to the SNA core through a single hairpin-shaped molecule to prevent guide strand dissociation is introduced and investigated. This hairpin-like architecture increases the number of siRNA duplexes that can be loaded onto an SNA by 4-fold compared to the original hybridized siRNA-SNA architecture. As a result, the hairpin-like siRNA-SNAs exhibit a 6-fold longer half-life in serum and decreased cytotoxicity. In addition, the hairpin-like siRNA-SNA produces more durable gene knockdown than the hybridized siRNA-SNA. This study shows how the chemistry used to immobilize siRNA on nanoparticles can markedly enhance biological function, and it establishes the hairpin-like architecture as a next-generation SNA construct that will be useful in life science and medical research.

Citing Articles

Cationic Metal-Organic Layer Delivers siRNAs to Overcome Radioresistance and Potentiate Cancer Radiotherapy.

Ma X, Jiang X, Wang Z, Fan Y, Li J, Chow C Angew Chem Int Ed Engl. 2024; 64(7):e202419409.

PMID: 39535730 PMC: 11811689. DOI: 10.1002/anie.202419409.

In Vivo Interactions of Nucleic Acid Nanostructures With Cells.

Xiao Y, Liang Z, Shyngys M, Baekova A, Cheung S, Muljadi M Adv Mater. 2024; 37(2):e2314232.

PMID: 39263835 PMC: 11733725. DOI: 10.1002/adma.202314232.

Recent advances in gene delivery nanoplatforms based on spherical nucleic acids.

Valatabar N, Oroojalian F, Kazemzadeh M, Mokhtarzadeh A, Safaralizadeh R, Sahebkar A J Nanobiotechnology. 2024; 22(1):386.

PMID: 38951806 PMC: 11218236. DOI: 10.1186/s12951-024-02648-5.

Extracellular Vesicle Spherical Nucleic Acids.

Chen H, Ding Q, Li L, Wei P, Niu Z, Kong T JACS Au. 2024; 4(6):2381-2392.

PMID: 38938802 PMC: 11200237. DOI: 10.1021/jacsau.4c00338.

Enhancing Endosomal Escape and Gene Regulation Activity for Spherical Nucleic Acids.

Park J, Evangelopoulos M, Vasher M, Kudruk S, Ramani N, Mayer V Small. 2023; 20(11):e2306902.

PMID: 37932003 PMC: 10947971. DOI: 10.1002/smll.202306902.

References

Barnaby S, Lee A, Mirkin C . Probing the inherent stability of siRNA immobilized on nanoparticle constructs. Proc Natl Acad Sci U S A. 2014; 111(27):9739-44. PMC: 4103361. DOI: 10.1073/pnas.1409431111. View

Mirkin C, LETSINGER R, Mucic R, Storhoff J . A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature. 1996; 382(6592):607-9. DOI: 10.1038/382607a0. View

Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001; 411(6836):494-8. DOI: 10.1038/35078107. View

Zheng D, Giljohann D, Chen D, Massich M, Wang X, Iordanov H . Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci U S A. 2012; 109(30):11975-80. PMC: 3409786. DOI: 10.1073/pnas.1118425109. View

Zhu S, Xing H, Gordiichuk P, Park J, Mirkin C . PLGA Spherical Nucleic Acids. Adv Mater. 2018; 30(22):e1707113. PMC: 6029717. DOI: 10.1002/adma.201707113. View

Kimling J, Maier M, Okenve B, Kotaidis V, Ballot H, Plech A . Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B. 2006; 110(32):15700-7. DOI: 10.1021/jp061667w. View

Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. DOI: 10.1038/35888. View

Choi C, Hao L, Narayan S, Auyeung E, Mirkin C . Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates. Proc Natl Acad Sci U S A. 2013; 110(19):7625-30. PMC: 3651452. DOI: 10.1073/pnas.1305804110. View

Yamankurt G, Stawicki R, Posadas D, Nguyen J, Carthew R, Mirkin C . The effector mechanism of siRNA spherical nucleic acids. Proc Natl Acad Sci U S A. 2020; 117(3):1312-1320. PMC: 6983385. DOI: 10.1073/pnas.1915907117. View

10.

Giljohann D, Seferos D, Prigodich A, Patel P, Mirkin C . Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc. 2009; 131(6):2072-3. PMC: 2843496. DOI: 10.1021/ja808719p. View

11.

Sorensen D, Leirdal M, Sioud M . Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol. 2003; 327(4):761-6. DOI: 10.1016/s0022-2836(03)00181-5. View

12.

Randeria P, Jones M, Kohlstedt K, Banga R, Olvera de la Cruz M, Schatz G . What controls the hybridization thermodynamics of spherical nucleic acids?. J Am Chem Soc. 2015; 137(10):3486-9. PMC: 5490082. DOI: 10.1021/jacs.5b00670. View

13.

Banga R, Chernyak N, Narayan S, Nguyen S, Mirkin C . Liposomal spherical nucleic acids. J Am Chem Soc. 2014; 136(28):9866-9. PMC: 4280063. DOI: 10.1021/ja504845f. View

14.

Petrocca F, Lieberman J . Promise and challenge of RNA interference-based therapy for cancer. J Clin Oncol. 2010; 29(6):747-54. DOI: 10.1200/JCO.2009.27.6287. View

15.

Mitri Z, Constantine T, ORegan R . The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2013; 2012:743193. PMC: 3539433. DOI: 10.1155/2012/743193. View

16.

Seferos D, Prigodich A, Giljohann D, Patel P, Mirkin C . Polyvalent DNA nanoparticle conjugates stabilize nucleic acids. Nano Lett. 2008; 9(1):308-11. PMC: 3918421. DOI: 10.1021/nl802958f. View

17.

Jensen S, Day E, Ko C, Hurley L, Luciano J, Kouri F . Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med. 2013; 5(209):209ra152. PMC: 4017940. DOI: 10.1126/scitranslmed.3006839. View

18.

Shim M, Kwon Y . Efficient and targeted delivery of siRNA in vivo. FEBS J. 2010; 277(23):4814-27. DOI: 10.1111/j.1742-4658.2010.07904.x. View

19.

Randeria P, Seeger M, Wang X, Wilson H, Shipp D, Mirkin C . siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown. Proc Natl Acad Sci U S A. 2015; 112(18):5573-8. PMC: 4426446. DOI: 10.1073/pnas.1505951112. View

20.

Kumthekar P, Ko C, Paunesku T, Dixit K, Sonabend A, Bloch O . A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Sci Transl Med. 2021; 13(584). PMC: 8272521. DOI: 10.1126/scitranslmed.abb3945. View